#sitc search results
My first #SITC was unforgettable. From advocating for cancer research on Capitol Hill and presenting our work at the poster session to connecting with inspiring colleagues, and of course, having fun at the mandatory Checkpoints concert! Grateful to be part of this amazing…
Join us in congratulating Moffitt President and CEO, Patrick Hwu, MD, on being recognized as a Champion of SITC! This honor celebrates 40 leaders who have advanced #SITC’s mission to drive innovation, education and collaboration in cancer immunotherapy. Congratulations,…
📢 El Dr. Ignacio Melero, codirector de Inmunología e Inmunoterapia en la Clínica y @CIMA_unav , ha sido reconocido por la #SITC por su impulso global al tratamiento oncológico. Sus avances en inmunoterapia intratumoral y la proteína 4-1BB han ampliado las opciones para…
What an unforgettable night with The Checkpoints celebrating #SITC’s 40th Anniversary! 🎶 Extra special having my sisters Peggy, Cathy and Susan here for all the fun. #SITC25 #Immunotherapy #TheCheckpoints #MoffittSITC25
When your science babies meet at a conference ❤️❤️❤️ #SITC @SMaratheTweets @LauraSipe3 #Makowskilab alum
@DispatchBio, a PICI-founded company, introduced its first clinical program, DISP-10, alongside new preclinical data. The updates convey the promise of DISP-10 & the Flare platform, which seek to address hurdles in treating solid tumors. #SITC Read more: bit.ly/49GKUKb
This week at #SITC25, we unveiled our first therapeutic program, DISP-10. The preclinical findings underscore DISP-10’s potential to make a meaningful impact for patients. Listen below as our CSO describes DISP-10, & co-founder + CPO shares key takeaways.
Thrilled to be here in San Diego to present our next generation drug platform for treating patients with solid tumors #sitc #maat @MaaT_Pharma @NathalieCorvaia @BLaperrousaz
Thank you @KristenHege @MyOncology and @sitcancer for inviting me to speak about the new paradigm of viral immunotherapy of cancer at the Annual Meeting of #SITC
Wonderful recognition of Dr. Marc Theoret by #SITC at #SITC2025 Who during 16 years at @FDAOncology worked to bridge the #scientific and #regulatory communities to support bench-to-bedside clinical trials accelerating delivery of novel #immunotherapies to patients with #cancer
Had an amazing time at the #SITC SCION workshop in Austin! Learned so much about clinical protocol development from true experts in the field. Grateful for the opportunity to connect, learn and grow with such a talented group! @sitcancer #SCION
Excited to present my latest work using a multiple instance #deeplearning approach in single-cell spatial IHC data to predict clinical outcomes in #CheckMate275 (nivolumab in metastatic urothelial carcinoma after platinum therapy)! See you at #SITC in beautiful San Diego in a…
@LealTiciana @eladgil @NarjustFlorezMD Thank you for a great panel on Society for immunotherapy of Cancer #Sitc
A first #SITC to remember! 🎉 From the Hill to the poster hall to the dance floor—what a way to experience the power of the #Immunotherapy community 🙌
What a debut, Ayesha! 🙌 Advocacy, science, connection—and a Checkpoints concert to top it off? #SITC really knows how to make an impact 🎤🧬 #Immunotherapy
My first #SITC was unforgettable. From advocating for cancer research on Capitol Hill and presenting our work at the poster session to connecting with inspiring colleagues, and of course, having fun at the mandatory Checkpoints concert! Grateful to be part of this amazing…
@DispatchBio, a PICI-founded company, introduced its first clinical program, DISP-10, alongside new preclinical data. The updates convey the promise of DISP-10 & the Flare platform, which seek to address hurdles in treating solid tumors. #SITC Read more: bit.ly/49GKUKb
This week at #SITC25, we unveiled our first therapeutic program, DISP-10. The preclinical findings underscore DISP-10’s potential to make a meaningful impact for patients. Listen below as our CSO describes DISP-10, & co-founder + CPO shares key takeaways.
#SITC2025 poster highlight 💫 Yingxiao Shi, Harvard Medical School: Multimodal analysis of mucosal melanoma reveals genomic and microenvironmental factors linked to treatment response and progression. Abstract: jitc.bmj.com/content/13/Sup… #SITC #Melanoma #SpatialBiology
Attend #SITC Winter School and learn the core principles of #tumor #immunology, #cancer #immunotherapy, biomarker technology, validation and clinical integration. Register at sitcancer.org/edu/winterscho… Register by Dec. 19 and save up to $250.
What an unforgettable night with The Checkpoints celebrating #SITC’s 40th Anniversary! 🎶 Extra special having my sisters Peggy, Cathy and Susan here for all the fun. #SITC25 #Immunotherapy #TheCheckpoints #MoffittSITC25
Gaurav Shrestha, PhD (The Ohio State University) showcasing his winning calendar image at our #SITC booth! 📆 Calendar image: Renal cell carcinoma, taken on the Orion platform Snag a 2026 calendar at Booth #503! 🎉 View all calendar images: rarecyte.com/2026calendar/ #SITC2025
Thank you @KristenHege @MyOncology and @sitcancer for inviting me to speak about the new paradigm of viral immunotherapy of cancer at the Annual Meeting of #SITC
Join us in congratulating Moffitt President and CEO, Patrick Hwu, MD, on being recognized as a Champion of SITC! This honor celebrates 40 leaders who have advanced #SITC’s mission to drive innovation, education and collaboration in cancer immunotherapy. Congratulations,…
When your science babies meet at a conference ❤️❤️❤️ #SITC @SMaratheTweets @LauraSipe3 #Makowskilab alum
Day 1 at #SITC I will present our project Tumor microenvironment changes after treatment with avelumab and immune-stimulating agent combinations in patients with advanced solid tumor during poster session. Very excited to be here. @ANaingMD @HaymakerCa15357 @kchenken
📢 El Dr. Ignacio Melero, codirector de Inmunología e Inmunoterapia en la Clínica y @CIMA_unav , ha sido reconocido por la #SITC por su impulso global al tratamiento oncológico. Sus avances en inmunoterapia intratumoral y la proteína 4-1BB han ampliado las opciones para…
Wonderful recognition of Dr. Marc Theoret by #SITC at #SITC2025 Who during 16 years at @FDAOncology worked to bridge the #scientific and #regulatory communities to support bench-to-bedside clinical trials accelerating delivery of novel #immunotherapies to patients with #cancer
I had lots of fun delivering our @Saints_Trust Goals for Growth project this afternoon at McDiarmid Park. With it being Bonfire Night, the children loved taking part in the ‘Find the Firework’ Scoreboard game. #scoreboardsoccer #SITC #morethanfootball
Attending #SITC2025 this week? We’re excited to meet with you and share the latest advancements in spatial biology for cancer immunotherapy. Make sure we connect by scheduling a meeting with us at our booth: calendly.com/rarecyte-sales… #SITC #Immunotherapy #SpatialBiology
My first #SITC was unforgettable. From advocating for cancer research on Capitol Hill and presenting our work at the poster session to connecting with inspiring colleagues, and of course, having fun at the mandatory Checkpoints concert! Grateful to be part of this amazing…
Join us in congratulating Moffitt President and CEO, Patrick Hwu, MD, on being recognized as a Champion of SITC! This honor celebrates 40 leaders who have advanced #SITC’s mission to drive innovation, education and collaboration in cancer immunotherapy. Congratulations,…
When your science babies meet at a conference ❤️❤️❤️ #SITC @SMaratheTweets @LauraSipe3 #Makowskilab alum
What an unforgettable night with The Checkpoints celebrating #SITC’s 40th Anniversary! 🎶 Extra special having my sisters Peggy, Cathy and Susan here for all the fun. #SITC25 #Immunotherapy #TheCheckpoints #MoffittSITC25
Wonderful talk by Dr. Tina Cascone at the #SITC Summit on the Future of Neoadjuvant Clinical Trial Design, highlighting the evolution from NEOCOAST to NEOCOAST2, creating a platform to explore novel agents & facilitate go/no-go decisions rapidly with translational correlates.
Thrilled to be here in San Diego to present our next generation drug platform for treating patients with solid tumors #sitc #maat @MaaT_Pharma @NathalieCorvaia @BLaperrousaz
Excited to present my latest work using a multiple instance #deeplearning approach in single-cell spatial IHC data to predict clinical outcomes in #CheckMate275 (nivolumab in metastatic urothelial carcinoma after platinum therapy)! See you at #SITC in beautiful San Diego in a…
Shout out to Dr. Bob Schrieber who proposed the concept of cancer immunoediting and is a pioneer of personalized cancer vaccines. #SITC #sitc2023 #immunotherapies @sitcancer @jitcancer
Had an amazing time at the #SITC SCION workshop in Austin! Learned so much about clinical protocol development from true experts in the field. Grateful for the opportunity to connect, learn and grow with such a talented group! @sitcancer #SCION
Modeling tumor heterogeneity helps us to better understand mechanism of immunotherapy resistance demonstrating pockets of immune suppression. Great talk from Melissa Reeves. @sitcancer #SITC2023 #sitc #SITC23
SITC and Xiamen Port Holding Group sign cooperation deal #SITC #XIAMENPORTHOLDINGGROUP bit.ly/48z87dV
Something went wrong.
Something went wrong.
United States Trends
- 1. #CashAppGreen N/A
- 2. #FanCashDropPromotion 2,792 posts
- 3. hayley 14.8K posts
- 4. Rondo 2,269 posts
- 5. Wale 41.7K posts
- 6. Summer Walker 31.6K posts
- 7. #FridayVibes 6,410 posts
- 8. Bubba 15.5K posts
- 9. #FursuitFriday 12.9K posts
- 10. Bill Clinton 80K posts
- 11. Reid Hoffman 23K posts
- 12. Bart Scott N/A
- 13. Hunter Biden 11.4K posts
- 14. Good Friday 66.6K posts
- 15. #LCxCODSweepstakes N/A
- 16. Thomas Crooks 50.2K posts
- 17. Ticketmaster 8,463 posts
- 18. SINGSA LATAI EP3 160K posts
- 19. Meek 6,974 posts
- 20. Go Girl 26.5K posts